157 bpc peptide Orthopedic Use of BPC-157 Heal or Harm: Body Protective

It reflects the hypothesis that a locally acting angiogenic peptide and a systemically acting migration peptide may complement one another in tissue-repair research

We Respond in Minutes, Not Days We take pride in providing excellent support we're here for your total research success

The standard protocol combines daily BPC-157 at 0.25 to 0.5 mg with TB-500 at 5 mg weekly during the loading phase, typically split into 2.5 mg doses twice weekly

Please review our Terms & Conditions before placing an order

We will not recommend a human dose but we can show what a vial of each format yields: Cross-check the published preclinical doses in our SLU-PP-332 Dosing Guide before committing to any format

While this is educational information rather than medical advice, understanding the most common applications can help you determine if further research is warranted for your situation